Clinical Trials
17 trialsNCT04671667 2026-05-08
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT03180268 2026-05-07
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Phase 3 Recruiting
NCT03801876 2026-05-07
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
NRG Oncology
Phase 3 Recruiting
NCT04946357 2026-04-06
EXTREM ION
University Hospital Heidelberg
Phase NA Recruiting
NCT03049072 2026-03-23
REGI-MA-002015
EBG MedAustron GmbH
Recruiting
NCT04894643 2026-03-20
PARC
EBG MedAustron GmbH
Phase NA Recruiting
NCT04083937 2026-03-09
PAROS
University Hospital Heidelberg
Phase NA Recruiting
NCT04278118 2026-02-17
HiPPI
Emory University
Phase NA Recruiting
NCT04725903 2026-02-17
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
Emory University
Phase NA Recruiting
NCT04656041 2025-11-14
Folfox+Irinotecan+Chemort In Esophageal Cancer
Massachusetts General Hospital
Phase 2 Recruiting
NCT06008730 2025-11-10
Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer
Emory University
Phase 2 Recruiting
NCT00969111 2025-09-09
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Proton Collaborative Group
Phase NA Recruiting
NCT04342429 2025-07-15
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Emory University
Phase NA Recruiting
NCT02824731 2024-12-16
Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)
Technische Universität Dresden
Phase NA Recruiting
NCT05159193 2024-02-02
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3 Recruiting
NCT05106699 2021-11-04
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
Shanghai Proton and Heavy Ion Center
Phase NA Recruiting
NCT02838602 2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA Recruiting